These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2988692)

  • 1. HTLV-III, haemophilia, and blood transfusion.
    Bloom AL; Forbes CD; Rizza CR
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1901-2. PubMed ID: 2988692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood transfusion, haemophilia, and AIDS.
    Lancet; 1984 Dec; 2(8417-8418):1433-5. PubMed ID: 6151047
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products.
    Erfle V; Hehlmann R; Mellert W; Goebel FD; Rasokat H; Lechler E; Hellstern P; Köhler M; Seifried E; Heimpel H
    Blut; 1985 Oct; 51(4):243-9. PubMed ID: 2996664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 8. [2 cases of AIDS in patients with hemophilia A].
    Jacob L; Sereni D; Maisonneuve P; Bardin JM; Cattan E; Sultan Y; Cremer GA; Laroche C
    Ann Med Interne (Paris); 1986; 137(7):562-4. PubMed ID: 3028224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV and haemophilia.
    Lee CA; Kernoff PB; Bofill M; Rizza CR; Downing RG
    Lancet; 1984 May; 1(8384):1028. PubMed ID: 6143962
    [No Abstract]   [Full Text] [Related]  

  • 10. HTLV-III infection associated with glandular-fever-like illness in a haemophiliac.
    Tucker J; Ludlam CA; Craig A; Philp I; Steel CM; Tedder RS; Cheingsong-Popov R; Macnicol MF; McClelland DB; Boulton FE
    Lancet; 1985 Mar; 1(8428):585. PubMed ID: 2857938
    [No Abstract]   [Full Text] [Related]  

  • 11. HTLV-III, haemophilia and blood transfusion.
    Mitchell VE; Martin C; Flower AJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):213. PubMed ID: 2990635
    [No Abstract]   [Full Text] [Related]  

  • 12. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of antibodies to HTLV-III/LAV virus in family members who administer coagulation products in home treatment programmes.
    Ekert H; McNaught KL
    Med J Aust; 1986 Jun; 144(13):722-3. PubMed ID: 3014283
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in prevalence of anti-HTLV-III in haemophiliacs.
    Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
    Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
    [No Abstract]   [Full Text] [Related]  

  • 18. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 19. [AIDS, transfusion and hemophilia, still a mysterious relationship. Comments and hypotheses].
    Bach JF
    Rev Fr Transfus Immunohematol; 1984 Sep; 27(4):455-8. PubMed ID: 6095409
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of hemophilia A with seroconversion to human T-lymphotropic virus III.
    Shingu T; Yamamoto K; Kashiwagi S; Kajiyama W; Hayashida K; Kaji M
    Kurume Med J; 1985; 32(4):297-300. PubMed ID: 3018355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.